Hangzhou Bio-Sincerity Pharma-Tech Co (SZSE:301096) Total Liabilities : ¥1,093 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Hangzhou Bio-Sincerity Pharma-Tech Co Total Liabilities?

Hangzhou Bio-Sincerity Pharma-Tech Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥1,093 Mil.

Hangzhou Bio-Sincerity Pharma-Tech Co's quarterly Total Liabilities increased from Sep. 2023 (¥805.82 Mil) to Dec. 2023 (¥984.97 Mil) and increased from Dec. 2023 (¥984.97 Mil) to Mar. 2024 (¥1,093.30 Mil).

Hangzhou Bio-Sincerity Pharma-Tech Co's annual Total Liabilities declined from Dec. 2021 (¥607.10 Mil) to Dec. 2022 (¥447.45 Mil) but then increased from Dec. 2022 (¥447.45 Mil) to Dec. 2023 (¥984.97 Mil).

Hangzhou Bio-Sincerity Pharma-Tech Co Total Liabilities Historical Data

The historical data trend for Hangzhou Bio-Sincerity Pharma-Tech Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Bio-Sincerity Pharma-Tech Co Total Liabilities Chart

Hangzhou Bio-Sincerity Pharma-Tech Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

99.89

319.20

607.10

447.45

984.97

Hangzhou Bio-Sincerity Pharma-Tech Co Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															712.94	836.83	805.82	984.97	1,093.30

Hangzhou Bio-Sincerity Pharma-Tech Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Hangzhou Bio-Sincerity Pharma-Tech Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	846.191	+	(0.933	+	137.845
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	985

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	3669.106	-	2684.137
	=	985

Hangzhou Bio-Sincerity Pharma-Tech Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	963.418	+	(0.913	+	128.971
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,093

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	3834.691	-	2741.389
	=	1,093

Hangzhou Bio-Sincerity Pharma-Tech Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Hangzhou Bio-Sincerity Pharma-Tech Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou Bio-Sincerity Pharma-Tech Co (SZSE:301096) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hangzhou Bio-Sincerity Pharma-Tech Co Ltd (SZSE:301096) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

611 Dongguan Road, 2nd Floor, Building 8, Jinsheng Technology Park, Binjiang District, Hangzhou, CHN

Website

https://www.hzbio-s.com

Hangzhou Bio-Sincerity Pharma-Tech Co Ltd is a pharmaceutical technology research and development company. The company's business covers drug discovery, pharmaceutical research, clinical research, and registration application.

Hangzhou Bio-Sincerity Pharma-Tech Co (SZSE:301096) Headlines

No Headlines